Although the tumor suppressor genes K-ras, p53, CDKN2A and SMAD4 have found to be the central molecular genetic pathways in pancreatic cancer33, 34, 35, 36, the gained survival advantage targeting aforementioned pathways remain limited. Here, KRAS is linked to neoplasm.